Smith-Whitley Kim 4
4 · Global Blood Therapeutics, Inc. · Filed Jun 3, 2022
Insider Transaction Report
Form 4
Smith-Whitley Kim
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2022-06-01+6,040→ 6,040 total - Tax Payment
Common Stock
2022-06-01$24.02/sh−1,660$39,873→ 4,380 total - Exercise/Conversion
Restricted Stock Units
2022-06-01−6,040→ 18,120 total→ Common Stock (6,040 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.
- [F2]Represents the number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligations in connection with the vesting of 6,040 shares of Common Stock underlying the Reporting Person's RSUs.
- [F3]The shares of Common Stock underlying the RSUs vested with respect to 25% of the underlying shares on June 1, 2022 and will vest in six equal semi-annual installments thereafter, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.